Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Switch to English

10965	Sociétés
240137	Mots-clés
168910	Articles
129233	Communiqués

Accueil
Sociétés
Onco-Innovations Limited

COMMUNIQUÉ DE PRESSE

publié le 27/10/2025 à 22:15, il y a 10 mois 15 jours

Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited closes non-brokered private placement, issuing 1,428,570 units for gross proceeds of $2,000,000. Funds to be used for corporate purposes and cancer research. Statutory hold period applies to securities issued

Private Placement Securities Cancer Research Statutory Hold Period Onco-Innovations Limited
BRÈVE

publiée le 15/10/2025 à 02:05, il y a 10 mois 28 jours

Onco-Innovations Announces $2 Million Private Placement

Private Placement Warrants Regulatory Approval Onco-Innovations Christopher Gulka
BRÈVE

publiée le 15/10/2025 à 02:05, il y a 10 mois 28 jours

Onco-Innovations annonce un placement privé de 2 millions de dollars

Placement Privé Mandats Approbation Réglementaire Onco-Innovations Christophe Gulka
COMMUNIQUÉ DE PRESSE

publié le 15/10/2025 à 02:00, il y a 10 mois 28 jours

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces non-brokered private placement of up to $2,000,000 and appointment of Mr. Christopher Gulka to the Board of Directors

Board Of Directors Private Placement Appointment Onco-Innovations Limited Christopher Gulka
BRÈVE

publiée le 29/09/2025 à 06:05, il y a 11 mois 13 jours

Onco-Innovations et Nucro-Technics lancent le programme préclinique PNKP

Etudes Précliniques Onco-Innovations Technologie PNKP Nucro-Techniques Développement Analytique
BRÈVE

publiée le 29/09/2025 à 06:05, il y a 11 mois 13 jours

Onco-Innovations and Nucro-Technics Initiate Preclinical PNKP Program

Preclinical Studies Onco-Innovations PNKP Technology Nucro-Technics Analytical Development
COMMUNIQUÉ DE PRESSE

publié le 29/09/2025 à 06:00, il y a 11 mois 13 jours

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS

Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRÈVE

publiée le 22/09/2025 à 23:05, il y a 11 mois 19 jours

Onco-Innovations Appoints Dr. Michael Lock to Advisory Board

Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
BRÈVE

publiée le 22/09/2025 à 23:05, il y a 11 mois 19 jours

Onco-Innovations nomme le Dr Michael Lock au conseil consultatif

Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
COMMUNIQUÉ DE PRESSE

publié le 22/09/2025 à 23:00, il y a 11 mois 19 jours

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel

Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design

Les Echos

Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures

Transparantiekennisgeving van Baltisse Groep
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures

Transparency notification by Baltisse Group
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 1 jour 20 heures

Availability of the 2026 Interim Financial Report

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 12/09/2026 à 02:35, il y a 13 heures 5 minutes

Gamma Resources Announces Extension of Private Placement Closing Date
Publié le 11/09/2026 à 23:00, il y a 16 heures 40 minutes

Rio Grande Resources Engages Machai Capital for Investor Outreach
Publié le 11/09/2026 à 22:05, il y a 17 heures 35 minutes

Usha Resources Announces Leadership Transition
Publié le 11/09/2026 à 21:25, il y a 18 heures 15 minutes

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Publié le 11/09/2026 à 17:00, il y a 22 heures 40 minutes

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

Voir tout ACCESSWIRE

EQS Group

Publié le 12/09/2026 à 07:30, il y a 8 heures 10 minutes

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Publié le 11/09/2026 à 22:15, il y a 17 heures 25 minutes

Amrize Appoints Mario Gross as President of Building Envelope
Publié le 11/09/2026 à 22:10, il y a 17 heures 30 minutes

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Publié le 11/09/2026 à 19:44, il y a 19 heures 56 minutes

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Publié le 11/09/2026 à 18:15, il y a 21 heures 25 minutes

CGTN: How BRICS creates new opportunities for Global South development